Common drug could protect inflamed hearts from lasting damage
NCT ID NCT05855746
Summary
This trial is testing if adding the anti-inflammatory drug colchicine to standard care can reduce heart scarring and prevent serious complications in people with acute myocarditis, a sudden inflammation of the heart muscle often caused by viruses. It will involve 300 hospitalized patients who will receive either colchicine or a placebo pill for three months. The main goal is to see if the drug leads to less permanent heart damage on scans and lowers the risk of heart failure, dangerous heart rhythms, or death over six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut de Cardiologie - APHP Pitié Salpêtrière
RECRUITINGParis, 75013, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Unité de Soins Intensifs Cardiologiques - Hôpital Cardiovasculaire Louis Pradel
RECRUITINGBron, 69029, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.